You just read:

BioMarin Receives Standard Approval for Palynziq™ (pegvaliase-pqpz) Injection for Treatment of Adults with Phenylketonuria (PKU), a Rare Genetic Disease

News provided by

BioMarin Pharmaceutical Inc.

May 24, 2018, 05:42 ET